| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Total Operating Expense | 3,057.91 | 2,729.79 | 2,556.85 | 1,949.65 |
| Other Net | -1.88 | -5.47 | -4.63 | -1.42 |
| Diluted Weighted Average Shares | 15.87 | 15.86 | 15.66 | 15.47 |
| Gain( Loss)on Saleof Assets | 0.21 | -0.23 | 0.01 | 2.40 |
| Depreciation/ Amortization | 171.04 | 138.32 | 114.41 | 72.66 |
| Operating Income | 860.08 | 754.39 | 592.43 | 474.60 |
| Net Income | 659.58 | 552.63 | 409.84 | 385.36 |
| Income Availableto Com Excl Extra Ord | 659.58 | 552.63 | 409.84 | 385.36 |
| Other Operating Expenses Total | 79.96 | 68.55 | 72.20 | 60.46 |
| Net Income Before Taxes | 887.39 | 751.51 | 555.23 | 504.90 |
| Minority Interest | 0.00 | 0.00 | -0.17 | -0.68 |
| Net Income After Taxes | 659.58 | 552.63 | 410.01 | 386.04 |
| Income Availableto Com Incl Extra Ord | 659.58 | 552.63 | 409.84 | 385.36 |
| Costof Revenue Total | 1,424.27 | 1,291.03 | 1,276.34 | 934.85 |
| Gross Profit | 2,493.72 | 2,193.15 | 1,872.94 | 1,489.40 |
| Interest Inc( Exp) Net- Non- Op Total | 28.98 | 2.82 | -32.57 | 29.32 |
| Diluted Net Income | 659.58 | 552.63 | 409.84 | 385.36 |
| DPS- Common Stock Primary Issue | 15.50 | 12.25 | 8.88 | 8.25 |
| Provisionfor Income Taxes | 227.81 | 198.88 | 145.23 | 118.86 |
| period Type | - | - | - | - |
| Net Income Before Extra Items | 659.58 | 552.63 | 409.84 | 385.36 |
| Total Revenue | 3,917.99 | 3,484.18 | 3,149.28 | 2,424.24 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Revenue | 3,917.99 | 3,484.18 | 3,149.28 | 2,424.24 |
| Selling/ General/ Admin Expenses Total | 1,382.64 | 1,231.89 | 1,093.90 | 881.68 |
| Diluted Normalized EPS | 41.55 | 34.86 | 26.17 | 24.79 |
| Diluted EPS Excluding Extra Ord Items | 41.56 | 34.85 | 26.17 | 24.91 |
J B Chemicals and Pharmaceuticals Dividend J B Chemicals and Pharmaceuticals Bonus J B Chemicals and Pharmaceuticals News J B Chemicals and Pharmaceuticals AGM J B Chemicals and Pharmaceuticals Rights J B Chemicals and Pharmaceuticals Splits J B Chemicals and Pharmaceuticals Board Meetings J B Chemicals and Pharmaceuticals Key Metrics J B Chemicals and Pharmaceuticals Shareholdings J B Chemicals and Pharmaceuticals Balance Sheet J B Chemicals and Pharmaceuticals Cashflow J B Chemicals and Pharmaceuticals Q1 Results J B Chemicals and Pharmaceuticals Q2 Results J B Chemicals and Pharmaceuticals Q3 Results J B Chemicals and Pharmaceuticals Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks